...

 
Cannvas.Me
Sign Up For Free
  • Post Time Posted May 31, 2019
When word came out that the federal government was interested in knowing our conclusions on CBD, it seems to have spurred a wave of action. Approximately 140 people are signed up to testify at a public hearing in Silver Spring, Maryland, where agency representatives will consider testimony on the use and implementation of the drug.

Topics that may be covered include potency levels, potential drug interactions and delivery method of CBD products. The agency selected speakers among respondents to its open call for comment. Attendees of the upcoming meeting will hear the opinions of individuals from the business community as well as medical professionals, academics, agriculturists and consumer advocates.

Perhaps, given the expansion of the CBD industry as of late, it should come as no surprise that there are a lot of people who want to weigh in on the future of products made with the cannabinoid in the United States. Confusion has reigned ever since CBD was effectively legalized by the U.S. Farm Bill, allowing for production of the hemp from which the cannabinoid is derived.

Even so, many states continue to arrest people for CBD sales and possession. Several high profile cases of arrests have received media coverage recently, including a small town Louisiana shop owner and a great-grandmother who made the mistake of visiting Disney World with a bottle of oil in her purse. In New York, the Health Department has cautioned restaurants known to be selling edible products that have been infused with the cannabinoid.

Current estimates for the CBD industry’s growth are quite massive - one firm says sales could soar to $22 billion within the US by 2022.

There are currently 17 states that have laws that explicitly allow some usages of CBD. But at the moment, many of those involved in recommending, consuming and distributing the product face some potential repercussions from state and/or federal agencies, while the substance’s exact authorization from the FDA remains in doubt.

So the question that the public has asked to weigh in on - the fine points of how CBD should be bought and sold in the country - is not inconsequential.

The agency has warned companies that CBD is not currently legal to add to food, drinks or supplements. This spring, the FDA sent out warning shots to three companies in violation of current CBD guidelines; New Jersey’s Advanced Spine and Pain LLC, Washington’s Nutra Pure LLC, and Florida’s PotNetwork Holdings Inc. The warnings were based on unsubstantiated health claims that the brands has been making. It was far from the first time the agency had made such a move, but perhaps the most well-known incident since federal hemp legalization.

The agency’s commissioner Scott Gottlieb put together a working group this spring to examine the issue, including potential for liver damage.

One potential approach is that of the Consumer Healthcare Products Association, which has been presented to the FDA that CBD regulations run similar to the dosage guidelines used for Vitamin C.

Source: https://hightimes.com/news/140-people-scheduled-testify-first-day-fda-hearings-cbd/

This article is now marked as read.

Was this article helpful?

Review this article to help us continue creating and sharing relevant content.

Please note it may take up to two business days for reviews to be validated and published.

Reviews

Review this article to help us continue creating and sharing relevant content.

Write Review

Would you like to
make this review public?

Please disable your ad blocker to avoid issues using social plugins on Cannvas.Me. Thanks.
Close